BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25465324)

  • 21. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
    Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
    JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up.
    Gil RJ; Bil J; Legutko J; Pawłowski T; Gil KE; Dudek D; Costa RA
    Int J Cardiovasc Imaging; 2018 Mar; 34(3):353-365. PubMed ID: 28965166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI.
    Otto S; Nitsche K; Jung C; Kryvanos A; Zhylka A; Heitkamp K; Gutiérrez-Chico JL; Goebel B; Schulze PC; Figulla HR; Poerner TC
    BMC Cardiovasc Disord; 2017 Apr; 17(1):103. PubMed ID: 28441929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of neointimal proliferation and stent coverage after intracoronary therapy with drug-eluting devices in stable coronary artery disease: role of endothelial progenitor cells and interleukin-1 family cytokines.
    Otto S; Nitsche K; Jung C; Gassdorf J; Janiak F; Goebel B; Figulla HR; Poerner TC
    J Invasive Cardiol; 2014 Dec; 26(12):648-53. PubMed ID: 25480994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
    Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
    Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry.
    Heeger CH; Busjahn A; Hildebrand L; Fenski M; Lesche F; Meincke F; Kuck KH; Bergmann MW
    EuroIntervention; 2016 Jan; 11(9):1004-12. PubMed ID: 25287264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OCT analysis in patients with very late stent thrombosis.
    Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of IVOCT imaging of coronary artery metallic stents with neointimal coverage.
    Elahi S; Ho D; Feldman MD; Dijkstra J; Milner TE
    Int J Cardiovasc Imaging; 2015 Mar; 31(3):463-70. PubMed ID: 25395364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography.
    Feng T; Yundai C; Hongbin L; Lian C; Zhijun S; Jun G; Qinhua J; Tao Z
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1677-83. PubMed ID: 24030292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thin-cap fibroatheroma and large calcification at the proximal stent edge correlate with a high proportion of uncovered stent struts in the chronic phase.
    Ueda T; Uemura S; Watanabe M; Dote Y; Goryo Y; Sugawara Y; Soeda T; Okayama S; Kawata H; Kawakami R; Okura H; Saito Y
    Coron Artery Dis; 2016 Aug; 27(5):376-84. PubMed ID: 27164267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of angiographic late loss with neointimal coverage of drug-eluting stent struts on follow-up optical coherence tomography.
    Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1289-97. PubMed ID: 21863320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
    Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
    Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.